"Wyatt Earp, the gunslinger who helped tame the American West, once said, 'fast is fine but accuracy is final,'" Sharyn Alfonsi reported on Sunday's 60 Minutes. "The same thing could be said about testing for COVID-19." On March 16, as the new coronavirus was spreading in parts of the U.S. and there were few working diagnostic tests, "the Food and Drug Administration took the unprecedented step of allowing COVID antibody tests to flood the market without review."
"The promise of a new serology, or antibody blood test, that could determine if a person had been exposed to COVID-19 and developed 'protective' antibodies was being heralded as the next best thing" to diagnostic testing, 60 Minutes reported. But federal officials knew pretty quickly that this "'game-changer' that could get Americans back to work" wouldn't work, because many of the tests were seriously flawed, Anfonsi reported, citing a three-month investigation. They "continued to allow them to be sold anyway."
The FDA said it allowed these flawed tests to remain on the market for 50 days after a "careful balancing of risks and benefits." But Rep. Raja Krishnamoorthi (D-Ill.), who is investigating that decision, told 60 Minutes "we've never seen anything like this in terms of a policy which is basically an anything goes, Wild West type of approach to regulating a health care market." In late May, the FDA started pulling tests — 50 so far — "but by then it was too late," 60 Minutes reports. "The flawed antibody tests are still being used and the bad data collected from them is guiding critical decisions about when to reopen communities."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If you still want to get a serology test, Alfonsi said you should get checked two or three times using different tests to lower the risk of false positives — and even if you do turn out to have antibodies, there's no guarantee you have immunity from the coronavirus. Peter Weber
-
August 30 editorial cartoonsCartoons Saturday’s political cartoons include Volodymyr Zelenskyy and Donald Trump's role reversal and King George III
-
5 bullseye cartoons about the reasons for mass shootingsCartoons Artists take on gun worship, a price paid, and more
-
Lisa Cook and Trump's battle for control the US FedTalking Point The president's attempts to fire one of the Federal Reserve's seven governor is represents 'a stunning escalation' of his attacks on the US central bank
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance mergerSpeed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profitsSpeed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new highSpeed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
